Associated Papers
Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypes.
Kizilkaya HS et al.
Nature Metabolism, 2024
38871982 (PubMed )
Supplement: 42255_2024_1061_MOESM4_ESM.xlsx › All_UKBB_samples
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.
Scott RA et al.
Science Translational Medicine, 2016
Select a paper to view details